Biot to participate in CES 2022… To reveal ‘RAPIDS,’ a non-face-to-face sample collection robot

Biot Korea Co., Ltd. (CEO Young-joon Jang) will introduce their “RAPIDS Platform,” a non-face-to-face sample collection medical robot for respiratory virusesat the “CES 2022” which will be held in Las Vegas on January 5, 2022 (local time).

Firstin class medical device startup, Biot is a company that researches and develops medical robot systems, such as the automated molecular diagnosis system RAPIDS Platform and the medical device platform Stem Cell Navigator that is capable of physicallyadministering treatments.

Vaccines and COVID-19-related medical devices have become a hot topic around the world due to the prolonged COVID-19 pandemic, which has rampantly spread since early last year.

Biot will showcase their non-face-to-face sample collection medical robot, “RAPIDS Platform” at the CES 2022 exhibition, which brings together companies from all over the world.

Biot’s RAPIDS Platform is a robotic system that allows medical staff to perform the sample collection process for molecular diagnosis of the pandemic virus in a non-face-to-face manner, and is compatible with existing sample collection tools.

RAPIDS PlatformㅣSource –Biot Korea

Minimizing medical staff intervention and automating the current face-to-face sample collection procedure in a post-COVID-19 era is an exceptional solution toreducing costs, secondary infection of medical staff, and staff fatigue due to full-body protective clothing.

In addition, the robot system is also fitted with a pressure sensor that uses anatomical data to minimize side effects that may occur to the examinee during the collection process, further ensuring safety.

Using the robot systemin the fieldwill allow medical staff to control the number of samples collected per hour and will also be extremely useful and effective in battling COVID-19, as well as future novel respiratory infections.

Currently, domestic and foreign companies primarilyonly supply medical equipment to hospitals due to the nature of in-vitro diagnostic devices. But in the case of Pandemic viruses, it is important to have effective quarantine mitigations for new and modified viruses at airports and bays,which is why this product, which can collect non-face-to-face samples, is gaining popularity.

Young-joon Jang, CEO of Biot, said, “With the emergence of other variants such as Omicron, the need for a field-type molecular diagnostic test system for large-scale personnel is rising. In addition, resuming international trade and international events in a post-Covid era requires a rapid testing system for those who will engage in it. In line with this, Biot Korea will cooperate with many companies to quickly develop systems that can collect samples and diagnose molecules electronically.”

RAPIDS Platform ControllerㅣSource – Biot Korea

Meanwhile, CES, the world’s largest IT exhibition, is an exhibition where you can grasp the flow of the global home appliance industry at a glance. It is hosted by the Consumer Technology Association (CTA) and is held every January. AVING NEWS, which has been covering CES for 16 consecutive years, has been sending the most news around the world every year since 2006, and will host ‘Best of CES 2022’ to select the best innovative products and technologies and ‘BEST OF MADE IN KOREA’ to select notable Korean companies. In addition, AVING LIVE, which conveys issues at the CES site, will be held for 7 days including Media Day.

* Special Reporters: Ashley Kim, Joseph Choe, KidaiKIm, Dongkwan Kim, Mokkyung Lee, Sangun Choi, Yeawon Choi, Wansu Kim